Notices. DEPARTMENT OF JUSTICE
360 words·~2 min read·
/register/2002/01/08/02-418A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4410-09-M DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration By Notice dated May 14, 2001, and published in the **Federal Register** on May 30, 2001, (66 FR 29344), Mallinckrodt, Inc., Mallinckrodt & Second Streets, St. Louis, Missouri 63147, made application by renewal to the Drug Enforcement Administration
(DEA)to be registered as a bulk manufacturer of the basic classes of controlled substances listed below: Drug Schedule Tetrahydrocannabinols
(7370)I Dihydromorphine
(9145)I Amphetamine
(1100)II Methylphenidate
(1724)II Cocaine
(9041)II Codeine
(9050)II Diprenorphine
(9058)II Etorphine Hydrochloride
(9059)II Dihydrocodeine
(9120)II Oxycodone
(9143)II Hydromorphone
(9150)II Diphenoxylate
(9170)II Hydrocodone
(9193)II Levorphanol
(9220)II Meperidine
(9230)II Methadone
(9250)II Methadone-intermediate
(9254)II Dextropropoxyphene, bulk (non-dosage forms)
(9273)II Morphine
(9300)II Thebaine
(9333)II Opium extracts
(9610)II Opium fluid extract
(9620)II Opium tincture
(9630)II Opium powdered
(9639)II Opium granulated
(9640)II Levo-alphacetylmethadol
(9648)II Oxymorphone
(9652)II Noroxymorphone
(9668)II Alfentanil
(9737)II Sulfentanil
(9740)II Fentanyl
(9801)II The firm plans to manufacture the controlled substances for distribution as bulk products to its customers. No comments or objections were received. DEA has considered the factors in Title 21, United States Code, section 823(a) and determined that the registration of Mallinckrodt, Inc. to manufacture listed controlled substances is consistent with the public interest at this time. DEA has investigated a Mallinckrodt, Inc. on a regular basis to ensure that the company's continued registration is consistent with the public interest. These investigations have included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy Assistant Administrator, Office of Diversion Control, hereby orders that the application submitted by the above firm for registration as a bulk manufacturer of the basic classes of the controlled substances listed above is granted. Dated: December 21, 2001. Laura M. Nagel, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 02-418 Filed 1-7-02; 8:45 am]
Connectionstraces to 2
Traces to 2 documents
Citation graph
cites case law
Cites 2Cited by 0 across 0 sources